when did you start losing weight on semaglutide - Effective Medical Loss What to Expect During the

Dulaglutides safety profile is consistent with other GLP-1 receptor agonists, with transient nausea being the most frequently reported adverse event (14.6% incidence). Dose escalation from 0.75 to 1.5 mg is recommended after at least four weeks, based on individual glycemic control needs [57]

Standard protocols for all GLP-1 oral liquid formulations call for once-daily dosing

PRECAUTIONS: See also Warning section

This isn't a reason to avoid compounded injectable GLP-1s - it's a reason to make sure your provider explains exactly how to measure and administer your specific dose before your first injection, and to confirm that the compounding pharmacy provides appropriate syringe sizing for your prescribed dose

Because GLP-1 therapy works through appetite and fullness signaling, understanding how GLP-1 medications support weight loss can make the comparison between semaglutide and tirzepatide easier to understand